In a murine myocardial infarct model, with doses comparable to those employed in humans (0.1 mg/kg), colchicine attenuated the activation of NLRP3 inflammasome constituents over and above the decrement in inflammatory mediators [9,91,92]. The gene discussed is NLRP3; the disease is myocardial infarction.